Form 4: Accenture Director Receives Anti-Dilution RSU Grant

Sentiment:

Insider Transaction Report


Accenture plc Director Paula A. Price received a grant of 6 Class A ordinary shares as Restricted Share Units due to anti-dilution provisions following a cash dividend.

Summary

  • Accenture plc Director Paula A. Price was granted 6 Class A ordinary shares.
  • The grant was in the form of Restricted Share Units (RSUs).
  • The transaction occurred on August 15, 2025.
  • The shares were valued at $247.57 per share at the time of the grant.
  • This grant was made pursuant to anti-dilution provisions of previously awarded RSUs, reflecting Accenture's payment of a cash dividend.
  • Following this transaction, Paula A. Price directly beneficially owns 7,361 Class A ordinary shares.

Sentiment

Score: 6

Explanation: The filing indicates a routine, positive adjustment for an insider's equity holdings due to anti-dilution provisions, which is a standard and expected corporate governance practice. It's not a major positive for the company's overall outlook but is a neutral to slightly positive signal regarding internal equity management.

Positives

  • The grant of Restricted Share Units to a director indicates adherence to anti-dilution provisions, maintaining the value of existing equity awards.
  • The transaction reflects a routine adjustment for a cash dividend, ensuring fairness for RSU holders.

Future Outlook

This filing is a routine disclosure of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a standard equity compensation adjustment for a director, common practice in publicly traded companies to maintain the value of equity awards following corporate actions like cash dividends. It does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

  • The grant of RSUs as an anti-dilution measure for cash dividends is a standard practice in corporate equity compensation plans across various industries, including professional services like Accenture.
  • Companies such as IBM, Deloitte, and Capgemini, which also operate in the consulting and IT services sector, typically have similar anti-dilution provisions in their equity incentive plans to ensure that the value of outstanding equity awards is preserved when dividends are paid.
  • The specific number of shares granted (6) is small and reflects a precise calculation based on the dividend amount and the RSU terms, consistent with how such adjustments are typically handled.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Compensation AdjustmentGrant of Restricted Share Units (RSUs) to a director as an anti-dilution measure, reflecting the company's payment of a cash dividend.08/15/2025Ensures the value of previously granted equity awards is maintained for recipients, aligning with standard corporate governance practices for equity compensation plans.

Related Party Transactions

  • The transaction involves the grant of Restricted Share Units to Paula A. Price, a director of Accenture plc, which is a routine related-party transaction under the company's equity compensation plan.

Stakeholder Impact

  • Shareholders: The anti-dilution adjustment ensures that the value of equity awards held by insiders is maintained, which is a standard practice and generally viewed as fair by shareholders, as it aligns insider interests with long-term share value.
  • Employees (with RSUs): This transaction confirms the company's commitment to maintaining the value of equity awards through anti-dilution provisions, which is positive for all employees holding similar RSU awards.

Key Dates

DateDescription
08/15/2025Date of transaction for the RSU grant.
08/18/2025Date the filing was signed by the reporting person's attorney-in-fact.

Keywords

Accenture, ACN, SEC Form 4, Insider Transaction, Restricted Share Units, RSU, Director Compensation, Equity Grant, Anti-dilution, Dividend Adjustment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.